Compound 1024
Identifiers
- Canonical SMILES:
COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCN(CC1)C(C)=O
- IUPAC name:
1-[4-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazin-1-yl]ethanone
- InChi:
InChI=1S/C25H24F3N3O2S/c1-17(32)30-11-13-31(14-12-30)24-16-19(9-10-29-24)18-7-8-22(20(15-18)25(26,27)28)34-23-6-4-3-5-21(23)33-2/h3-10,15-16H,11-14H2,1-2H3
- InChiKey:
ABFZFLPVUIIHIL-UHFFFAOYSA-N
External links
21906783 |
CHEMBL181111 |
10657293 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 6.92 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 487.15 g/mol | |||
HBA | 5 | |||
HBD | 0 | |||
HBA + HBD | 5 | |||
AlogP | 5.09 | |||
TPSA | 45.67 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7467 | 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine | DB02177 | |
0.5393 | Netupitant | DB09048 | |
0.5179 | 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol | DB07969 | |
0.5025 | Bitopertin | DB12426 | |
0.4948 | Fosnetupitant | DB14019 | |
0.4722 | Mepyramine | DB06691 | |
0.4525 | Atevirdine | DB12264 | |
0.4360 | 4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine | DB03916 | |
0.4255 | Vortioxetine | DB09068 | |
0.4252 | ABT-384 | DB12501 | |
0.4213 | Blonanserin | DB09223 | |
0.4175 | Lecozotan | DB12540 | |
0.4136 | E-6005 | DB12776 | |
0.4114 | Tripelennamine | DB00792 | |
0.4076 | ORM-13070 C-11 | DB15324 |